Search results for "Delivery"

showing 10 items of 1271 documents

Official Statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) on Electronic Cigarettes and IQOS®.

2019

The use of novel tobacco products, particularly the electronic cigarette (EC) and partial tobacco combustion devices (HnB systems: Heat not Burn), has increased exponentially, particularly among adolescents and young people. The health authorities and scientific societies have shown concern about issues surrounding safety and effectiveness (as a method of smoking cessation). A study of the available scientific evidence has concluded that the safety of the vapor or fumes inhaled by the users of these devices cannot be guaranteed. Contradictory results from various clinical trials and meta-analyses also mean that these devices cannot be recommended for their effectiveness in cessation, especi…

medicine.medical_specialtymedicine.medical_treatmentRespiratory SystemElectronic Nicotine Delivery Systemslaw.inventionScientific evidence03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelawInternal medicineNeoplasmsmedicinePulmonary MedicineHumansVareniclineSocieties MedicalBupropionAerosolsbusiness.industryThoracic SurgeryGeneral MedicineNicotine replacement therapyTobacco Use Cessation DevicesClinical trialPulmonology030228 respiratory systemchemistryCardiovascular DiseasesSpainFamily medicineSmoking cessationSmoking CessationbusinessElectronic cigarettemedicine.drugArchivos de bronconeumologia
researchProduct

Maternal risk factors of urinary incontinence during pregnancy and postpartum: A prospective cohort study

2021

Highlights • Urinary incontinence after delivery affects every fifth woman. • Urinary incontinence before pregnancy is a risk factor of postpartum incontinence. • Primiparous women are at a greater risk of urinary incontinence after birth.

medicine.medical_specialtysynnytysprimiparityvirtsanpidätyskyvyttömyysUrinary incontinenceUrinary incontinenceraskausPrimiparityensisynnyttäjät3123 Gynaecology and paediatricsPregnancymedicineChildbirthProspective cohort studyPregnancyPelvic floorurinary incontinencebusiness.industryObstetricsVaginal deliveryIncidence (epidemiology)UrogynaecologyObstetrics and GynecologyriskitekijätGynecology and obstetricsStepwise regressionUI Urinary incontinencemedicine.diseasemedicine.anatomical_structureReproductive MedicinePFMT pelvic floor muscle trainingRG1-991pregnancymedicine.symptombusinessEuropean Journal of Obstetrics & Gynecology and Reproductive Biology: X
researchProduct

Novel cytokine-targeted therapies and intestinal inflammation

2009

Several cytokines have been identified as critical mediators of chronic inflammation in inflammatory bowel disease (IBD) and biological therapies that target these molecules have been developed during recent years. Thereby, anti-TNF agents have noticeably improved the treatment of patients with IBD in comparison to conventional therapy. Furthermore, initial clinical trials showed promising results with anti-IL-6 and anti-IL-12/IL-23 agents. In addition to these well-known mediators of IBD, various novel cytokines have been described as critical during the pathogenesis of IBD in recent experimental studies and therapeutic targeting of these cytokines could provide new strategies for human di…

medicine.medical_treatmentInflammationTherapeutic targetingInflammatory bowel diseaseAntibodiesPathogenesisDrug Delivery SystemsIntestinal inflammationDrug DiscoverymedicineAnimalsHumansIntestinal MucosaPharmacologyBiological therapiesbusiness.industryModels ImmunologicalColitisInflammatory Bowel Diseasesmedicine.diseasedigestive system diseasesIntestinesClinical trialDisease Models AnimalCytokineImmunologyCytokinesmedicine.symptombusinessCurrent Opinion in Pharmacology
researchProduct

A hyaluronic acid/cyclodextrin based injectable hydrogel for local doxorubicin delivery to solid tumors

2020

Localized delivery of anticancer drugs is often the most useful therapeutic approach for the treatment of solid tumors. The use of injectable polymeric systems that maximize drug concentration in the proximal area of the tumor represents an extremely advantageous therapeutic strategy. Here, the development of an injectable in situ forming hydrogel was accomplished by exploiting the azo-type Michael reaction between an amine derivative of hyaluronic and vinylsulfone functionalized -cyclodextrins complexing doxorubicin. This injectable system can be easily prepared and administered with timelines compatible with normal operating room procedures, as demonstrated by rheological tests. In vitro…

medicine.medical_treatmentPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineAnimal modelIn vivoNeoplasmsHyaluronic acidmedicineAnimalsDoxorubicinHyaluronic Acidchemistry.chemical_classificationCyclodextrinsChemotherapyCyclodextrinChemistryHydrogels021001 nanoscience & nanotechnologyIn vitroDrug concentrationDoxorubicinLocalized chemotherapy hyaluronic acid cyclodextrins in situ forming hydrogel DoxorubicinSettore CHIM/09 - Farmaceutico Tecnologico Applicativo0210 nano-technologyBiomedical engineeringmedicine.drug
researchProduct

Delivery of siHIF‐1α to Reconstruct Tumor Normoxic Microenvironment for Effective Chemotherapeutic and Photodynamic Anticancer Treatments

2021

The tumor hypoxic microenvironment not only induces genetic and epigenetic changes in tumor cells, immature vessels formation for oxygen demand, but also compromises the efficiency of therapeutic interventions. On the other hand, conventional therapeutic approaches which kill tumor cells or destroy tumor blood vessels to block nutrition and oxygen supply usually facilitate even harsher microenvironment. Thus, simultaneously relieving the strained response of tumor cells and blood vessels represents a promising strategy to reverse the adverse tumor hypoxic microenvironment. In the present study, an integrated amphiphilic system (RSCD) is designed based on Angiotensin II receptor blocker cand…

medicine.medical_treatmentPhotodynamic therapy02 engineering and technology010402 general chemistry01 natural sciencesBiomaterialsNeovascularizationchemistry.chemical_compoundIn vivoCell Line TumorTumor MicroenvironmentmedicineHumansGeneral Materials ScienceRNA Small InterferingHypoxiaChemotherapyTumor microenvironmentGeneral ChemistryHypoxia-Inducible Factor 1 alpha Subunit021001 nanoscience & nanotechnologyCell HypoxiaIn vitro0104 chemical sciencesOxygenchemistryDrug deliveryCancer researchmedicine.symptomGrowth inhibition0210 nano-technologyBiotechnologySmall
researchProduct

Spontaneous labour at term is associated with fetal monocyte activation.

1999

SUMMARYThe aetiology of both term and preterm labour remains incompletely understood. Maternal infectious diseases as well as intra-uterine infections were shown to be a well established cause of uncontrollable preterm delivery, indicating that inflammatory reactions, regulated by maternal immunecompetent cells, are implicated in labour-promoting mechanisms. To investigate the possibility that the activation of the fetal immune system may be involved in labour induction, we examined cytokine production patterns of different cord blood cell populations obtained from neonates after spontaneous onset of normal term labour and vaginal delivery (n = 25), vaginal delivery but induced term labour …

medicine.medical_treatmentT cellImmunologyInflammationGestational AgeBetamethasoneMonocytesMagnesium SulfateImmune systemFetusObstetric Labor PrematurePregnancymedicineImmunology and AllergyHumansLabor InducedLungreproductive and urinary physiologyFenoterolFetusLabor Obstetricbusiness.industryVaginal deliveryCesarean SectionInterleukin-6MonocyteInfant NewbornDelivery ObstetricFetal Bloodmedicine.anatomical_structureCytokineTocolytic AgentsCord bloodImmunologyFemaleOriginal Articlemedicine.symptombusinessClinical and experimental immunology
researchProduct

Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment.

2015

The immunostimulatory ability of synthetic oligonucleotides containing CpG motifs (CpG-ODN), agonists of Toll-like receptor 9 (TLR9), can be harnessed to promote antitumor immunity by their application at the tumor site to stimulate local activation of innate immunity; however, particularly in the lung, tumor-associated immunosuppression can subvert such antitumor innate immune responses. To locally maintain continuous activation of innate subpopulations while inhibiting immunosuppressive cells, we evaluated aerosol delivery CpG-ODN combined with Poly(I:C), a TLR3 agonist able to convert tumor-supporting macrophages to tumoricidal effectors, in the treatment of B16 melanoma lung metastases …

miceCpG Oligodeoxynucleotidemedicine.medical_treatmentDacarbazineImmunologySettore MED/08 - Anatomia Patologicaaerosol delivery; dacarbazin; lung metastases; mice; TLR agonists; Immunology and Allergy; Oncology; Immunologylung metastaseMedicineCytotoxic T cellImmunology and AllergyTLR agonistAerosolizationOriginal ResearchInnate immune systembusiness.industryTLR9Immunosuppressionhemic and immune systemsrespiratory systemOncologydacarbazinTLR3ImmunologyCancer researchaerosol deliverybusinessmedicine.drug
researchProduct

Synthesis of Biocompatible and Biodegradable Polyamidoamines Microgels via a Simple and Reliable Statistical Approach.

2022

Polyamidoamines (PAAs) are biocompatible and biodegradable polymers with a huge potential as biomaterials for pharmaceutical applications. They are obtained by the step-wise aza-Michael polyaddition of bifunctional or multifunctional amines with bisacrylamides in water. To the best of our knowledge, no synthetic protocols leading to hyperbranched PAAs as well as PAA microgels have been published so far. To fill this gap, a statistical approach was established in this work to fine-tune the aza-Michael polyaddition stoichiometry when a multifunctional co-monomer (bf) is added to a mixture of bifunctional monomers with complementary functions (a2 + b2), possibly even in presence of a monofunct…

microgelspolyamidoamines; microgels; drug delivery; polyaddition; biodegradable polymersSettore CHIM/09 - Farmaceutico Tecnologico Applicativopolyamidoaminesbiodegradable polymers; drug delivery; microgels; polyaddition; polyamidoamines;biodegradable polymersdrug deliveryGeneral Materials SciencepolyadditionSettore CHIM/04 - Chimica IndustrialeMaterials (Basel, Switzerland)
researchProduct

Rational Chemical Multifunctionalization of Graphene Interface Enhances Targeted Cancer Therapy

2020

The synthesis of a drug delivery platform based on graphene was achieved through a step‐by‐step strategy of selective amine deprotection and functionalization. The multifunctional graphene platform, functionalized with indocyanine green, folic acid, and doxorubicin showed an enhanced anticancer activity. The remarkable targeting capacity for cancer cells in combination with the synergistic effect of drug release and photothermal properties prove the great advantage of a combined chemo‐ and phototherapy based on graphene against cancer, opening the doors to future therapeutic applications of this type of material.

multifunctionalizationCarbon materialsCancer therapyAntineoplastic AgentsNanotechnology[CHIM.THER]Chemical Sciences/Medicinal Chemistry010402 general chemistry01 natural sciencesCatalysislaw.inventionDrug Delivery SystemslawCell Line TumorNeoplasmsmedicineHumanscancerDoxorubicindiazonium saltsCàncerMaterialsComputingMilieux_MISCELLANEOUSgraphite010405 organic chemistryGrapheneChemistryCancerGeneral MedicineGeneral ChemistryPhotothermal therapymedicine.disease0104 chemical sciencesDrug deliveryCancer cellSurface modificationmedicine.drugAngewandte Chemie International Edition
researchProduct

Practical Considerations for the Daratumumab Management in Portuguese Routine Clinical Practice: Recommendations From an Expert Panel of Hematologists

2022

The recent therapeutic progress in multiple myeloma (MM) has led to the introduction of novel and highly potent drug classes. Daratumumab was the first CD38-targeting antibody showing to be effective and safe in MM patients as monotherapy and in combination regimens, which led to its rapid implementation in clinical practice. Considering that treatment discontinuation for drug-related adverse events can impact patients’ quality of life and outcomes, the treatment decision should consider different factors and be weighted for each patient individually. Here, we aimed to guide clinicians using daratumumab treatment for MM by addressing practical real-world considerations based on an expert pa…

multiple myelomaCancer ResearchOncologydelivery of health careNeoplasms. Tumors. Oncology. Including cancer and carcinogensadverse reactionsdaratumumabdrug-related side effectsRC254-282Frontiers in Oncology
researchProduct